Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors.
Design, synthesis and biological evaluation of a series of 5-chloropyridine ester-derived severe acute respiratory syndrome-coronavirus chymotrypsin-like protease inhibitors is described. Position of the carboxylate functionality is critical to potency. Inhibitor 10 with a 5-chloropyridinyl ester at position 4 of the indole ring is the most potent inhibitor with a SARS-CoV 3CLpro IC(50) value of 30 nM and an antiviral EC(50) value of 6.9 microM. Molecular docking studies have provided possible binding modes of these inhibitors.
Ghosh
Arun K
AK
Department of Chemistry, Purdue University, 560 Oval drive, West Lafayette, IN 47907, USA. akghosh@purdue.edu
Gong
Gangli
G
Grum-Tokars
Valerie
V
Mulhearn
Debbie C
DC
Baker
Susan C
SC
Coughlin
Melissa
M
Prabhakar
Bellur S
BS
Sleeman
Katrina
K
Johnson
Michael E
ME
Mesecar
Andrew D
AD
D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D020134:Catalytic Domain; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D000086782:Coronavirus 3C Proteases; D003546:Cysteine Endopeptidases / Q000737:chemistry; D015195:Drug Design; D004952:Esters; D006801:Humans; D020128:Inhibitory Concentration 50; D008956:Models, Chemical; D008958:Models, Molecular; D008968:Molecular Conformation; D011485:Protein Binding; D045473:Severe acute respiratory syndrome-related coronavirus / Q000378:metabolism*; D014764:Viral Proteins / Q000037:antagonists & inhibitors*
D000998:Antiviral Agents; D004952:Esters; D014764:Viral Proteins; D003546:Cysteine Endopeptidases; D000086782:Coronavirus 3C Proteases
N Engl J Med. 2003 May 15;348(20):1953-66
12690092
Curr Opin Struct Biol. 2005 Dec;15(6):664-72
16263266
Chem Biol. 2008 Jun;15(6):597-606
18559270
Chem Biol. 2004 Oct;11(10):1445-53
15489171
Chem Biol. 2006 Mar;13(3):261-8
16638531
Proteins. 2003 Sep 1;52(4):609-23
12910460
Science. 2003 Jun 13;300(5626):1763-7
12746549
J Gen Virol. 2003 Sep;84(Pt 9):2305-2315
12917450
Annu Rep Med Chem. 2007 Feb 1;41:183-196
19649165
J Med Chem. 2005 Nov 3;48(22):6767-71
16250632
Bioorg Med Chem Lett. 2007 Nov 1;17(21):5876-80
17855091
J Med Chem. 2007 Apr 19;50(8):1850-64
17381079
N Engl J Med. 2003 May 15;348(20):1967-76
12690091
J Mol Biol. 2007 Feb 23;366(3):965-75
17189639
Curr Top Microbiol Immunol. 2005;287:57-94
15609509
Bioorg Med Chem. 2008 Jan 1;16(1):293-302
17931870
Virus Res. 2008 Apr;133(1):63-73
17397958
Biochem Biophys Res Commun. 2003 Aug 15;308(1):148-51
12890493
J Med Chem. 2005 Jan 13;48(1):134-40
15634007
Bioorg Med Chem. 2008 May 15;16(10):5761-77
18407505